9 September 2010

Colefax

Company Details

Address:
19-23 Grosvenor Hill , London W1K 3QD
Telephone:
020 7318 6000
Fax:
020 7499 9910
Email:
pressoffice@colefax.com
Website:
www.colefaxgroupplc.co.uk

Commentary

Wallpaper and luxury furnishing fabrics designer and distributor, and interior decorator

Executives

Chairman:
David Green (31% holding)
Chief Executive:
as above (% holding)
Finance Director:
Robert Barker (.7% holding)
Managing Director:
Wendy Nicholls (1.6% holding)

Main Shareholders

Discretionary Unit Fund Managers: 16.6%

Hunter Hall: 11.1%

Colefax: 4.9%

Advisers

Nominated Adviser:
KBC Peel Hunt
Nominated Broker:
KBC Peel Hunt
Solicitors:
SJ Berwin
Auditors:
BDO
Registrar:
Computershare Investor Services

Accounts Information

Entry on AIM:
19/8/2004
Issue Price:
n/a
Interim Results:
Jan
Final Results:
Jul
Year End:
Apr
Accounts Due:
Jul
Int div payment:
Apr
Fin div payment:
Oct
Int net div per share:
1.55
Fin net div per share:
1.55

Financial History

  2010 2009
Turnover: £67.38m £73.05m
Pre-tax profit: £ 4.38m £ 2.91m
EPS: 16.4 p 12.9 p

Associated Articles

Colefax Group 20/07/2009

Colefax 22/01/2002

Cash Shells Directory 2010

A comprehensive overview of cash shells on AIM and PLUS, companies that have become a significant feature on the market landscape. For more information and to order, click here or contact our marketing team on 020 7250 7056.

The AIM Guide Spring 2010

The new, fully updated AIM Guide is now available to buy for only £49.95 (saving you £30).

A 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today Hurry, as offer ends soon!

Popular News

Latest News

Futura hails product progress 08/09/2010

Consumer healthcare concern Futura Medical says it expects European approval this year for its CSD500 erection-maintaining condom.

Tags: AIM , Deals & contracts , Fundraisings , Growth Stocks

Sector: Pharmaceuticals & Biotechnology

Companies: Futura Medical

Dana details bid defence 08/09/2010

Dana Petroleum says its shares are worth between £22.70p and £24.65p to support its opposition to Korea National Oil Corporation's bid at £18.

Tags: Commodities , Full list , Growth Stocks

Sector: Oil & Gas Producers

Companies: Dana Petroleum

Abcam 'cautious' after strong growth 07/09/2010

Online antibody distributor Abcam fears public spending cuts might dampen growth after lifting annual pre-tax profits 58.4 per cent to £25.8 million.

Tags: AIM , Cash , Dividends , Growth Stocks

Sector: Pharmaceuticals & Biotechnology

Companies: Abcam

More News

Sectors

Vitesse Media Events